Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Aldevron's new division to produce and sell research and manufacturing services in Wisconsin

Aldevron, a biotechnology company based in Fargo, ND, has today announced that the company is expanding into Madison, WI. The new division will produce and sell contract research and manufacturing services marketed under the Aldevron brand.

24 Oct 2009

Blood Bank of Alaska licenses the LifeTrak blood donor management software

Mediware Information Systems, Inc. announced today that the Blood Bank of Alaska is the latest major blood center to license LifeTrak®, the company's 510(k) cleared blood donor management software. Using LifeTrak, the blood center plans to integrate core software systems, launch an additional mobile unit and increase the number of advanced collection machines, to help the center to more efficiently collect more blood products.

24 Oct 2009

Seattle Genetics reports its third-quarter financial results

Seattle Genetics, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development progress.

24 Oct 2009

Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia

The Washington Post examines H1N1 vaccine supplies across the U.S.: "With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots," the newspaper writes.

24 Oct 2009

Bend Research looking for partners to develop oligonucleotide delivery technologies

Bend Research Inc., a company with more than 30 years of experience in applying innovative pharmaceutical technologies to help clients solve their most difficult scientific and technical problems, is marking the one-year anniversary of a new initiative focused on meeting the needs of a broad range of U.S. and international clients.

23 Oct 2009

IDEXX Laboratories reports increased revenues for 2009 third quarter

IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2009 were $259.1 million compared to $251.1 million for the third quarter of 2008.

23 Oct 2009

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs.

23 Oct 2009

Phase Forward releases IRT 5.0 Interactive Response Technology solution

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a major new release of its Interactive Response Technology (IRT) solution, Phase Forward™ IRT 5.0.

22 Oct 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.

22 Oct 2009

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2009.

22 Oct 2009

Conference to discuss cost savings and payback of personal companion robots

GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to learn and discuss the expected cost savings and payback of personal companion robots, such as their CareBot, in an eldercare setting. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot (MSR) industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

22 Oct 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended September 30, 2009.

22 Oct 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter.

22 Oct 2009

PacificGMP selected by ArmaGen Technologies to produce its proprietary protein for a Phase 1 clinical trial

PacificGMP, the leader in single-use bioprocessing for development and manufacturing for its client partners, announced that ArmaGen Technologies has selected it to produce its proprietary protein for a Phase 1 clinical trial.

22 Oct 2009

Drug expert to discuss recent policy shift in medical marijuana at 2009 Symposium

The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.

22 Oct 2009

Fluorescent molecule to detect cyanide contamination in drinking water

A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.

22 Oct 2009

Laureate Pharma signs development and manufacturing agreement to develop fusion protein products

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with an undisclosed client.

22 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.

21 Oct 2009

Update from SemBioSys Genetics regarding Botaneco Specialty Ingredients

SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").

21 Oct 2009

Manufacturing News and Research

Further Reading

Aldevron's new division to produce and sell research and manufacturing services in Wisconsin

Blood Bank of Alaska licenses the LifeTrak blood donor management software

Seattle Genetics reports its third-quarter financial results

Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia

Bend Research looking for partners to develop oligonucleotide delivery technologies

IDEXX Laboratories reports increased revenues for 2009 third quarter

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Phase Forward releases IRT 5.0 Interactive Response Technology solution

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Decrease in sales for CONMED Corporation during third quarter ended September 30, 2009

Conference to discuss cost savings and payback of personal companion robots

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Schering-Plough announces 2009 third quarter financial results

PacificGMP selected by ArmaGen Technologies to produce its proprietary protein for a Phase 1 clinical trial

Drug expert to discuss recent policy shift in medical marijuana at 2009 Symposium

Fluorescent molecule to detect cyanide contamination in drinking water

Laureate Pharma signs development and manufacturing agreement to develop fusion protein products

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Novavax, Xcellerex enter into collaboration to accelerate the development of Novavax's 2009 H1N1 vaccine

Update from SemBioSys Genetics regarding Botaneco Specialty Ingredients

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®